Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001369783 | SCV001566232 | uncertain significance | Fanconi anemia | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 16 of the FANCA gene. It does not directly change the encoded amino acid sequence of the FANCA protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 1060359). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002488154 | SCV002790373 | uncertain significance | Fanconi anemia complementation group A | 2021-09-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001369783 | SCV002095028 | uncertain significance | Fanconi anemia | 2020-10-27 | no assertion criteria provided | clinical testing |